In tumor-bearing mice, the inhibition of SETD1B suppressed the H3K4me3 level at the Nos2 promoter region and diminished the inducible nitric oxide synthase expression in myeloid-derived suppressor cells (17). The gene discussed is NOS2; the disease is neoplasm.